Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 28 Feb 23 253G2 Offering circular supplement
- 17 Jan 23 1-A-W Offering statement withdrawal
- 11 Jan 23 1-A/A Offering $10.00 mm in Equity
- 31 Aug 21 253G2 Offering circular supplement
- 23 Feb 21 253G2 Offering circular supplement
- 3 Sep 20 253G2 Offering circular supplement
- 3 Sep 20 QUALIF Notice of qualification
- 25 Aug 20 1-A/A Offering $10M in Equity
- 10 Aug 20 1-A/A Offering $10M in Equity
- 29 Jul 20 1-A/A Offering $10M in Equity
- 1 Jul 20 1-A/A Offering $10M in Equity
-
29 May 20 1-A Offering $10M in Equity
Fisher Wallace Laboratories similar filings
Filing view
External links
Exhibit 11.1
CONSENT OF INDEPENDENT PUBLIC ACCOUNTING FIRM
May 29, 2020
Board of Directors
Fisher Wallace Laboratories, Inc.
We hereby consent to the inclusion in the Offering Circular filed under Regulation A tier 2 on Form 1-A of our reports dated April 24, 2020, with respect to the consolidated balance sheets of Fisher Wallace Laboratories, Inc. as of December 31, 2019 and 2018 and the related consolidated statements of operations, shareholders’ equity/deficit and cash flows for the calendar years ended December 31, 2019 and 2018 and the related notes to the financial statements.
/s/ IndigoSpire CPA Group |
IndigoSpire CPA Group, LLC
Aurora, Colorado
May 29, 2020